Regulatory Frameworks and Clinical Development of Orthobiologics Across Asia and Europe.

Asia and Europe are rapidly expanding hubs for orthobiologics, driven by aging populations, advancing infrastructure, and growing evidence for regenerative therapies. Regulatory heterogeneity across both regions remains a major barrier, highlighting the need for international collaboration to support safe, responsible innovation.